DuPont's FilmTec Hypershell XP RO-8038 boosts dairy processing with up to 50% more productivity or 50% less energy use.
New FilmTec™ Hypershell™ XP RO-8038 reverse osmosis element delivers enhanced productivity and performance, enabling high-quality dairy products WILMINGTON, Del. , June 26, 2025 /PRNewswire/ -- DuPont today announced the launch of FilmTec™ Hypershell™ XP RO-8038 element—an advanced reverse osmosis (RO) solution engineered to meet the evolving needs of the dairy processing industry.
WILMINGTON, Del. , June 25, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on September 15, 2025, to holders of record of said stock at the close of business on August 29, 2025.
Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del. , June 11, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A.
Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del. , June 10, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography.
DuPont's Costa Rica expansion introduces sterile healthcare packaging, a first for the region's medical device industry.
The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del.
TOKYO , June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at the Tokyo Big Sight East Exhibition Halls. At Booth #6C-03, DuPont will showcase its extensive portfolio of advanced interconnect solutions, which encompass fine line, signal integrity, power and thermal management.
Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.
DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.
DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.
Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications WILMINGTON, Del. , May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioprocessing portfolio with the launch of DuPont™ AmberChrom™ TQ1 chromatography resin for the purification of oligonucleotides and peptides in support of a wide-range of biopharma applications.